Jane Street
TTPH

Jane Street’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Jane Street’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,615
Closed -$539K – 4640
2015
Q3 		$539K Buy
+3,615
New +$2.65M ﹤0.01% 2241

Other funds holding TTPH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jane Street's TTPH Position: Q3 2019 in Review

Jane Street sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2019, closing a stake of 12,731 shares — an estimated $122K sold.

Jane Street first reported a position in TTPH in Q2 2015 and held it in 6 quarters. The position peaked at $264K in Q2 2015. 26 funds tracked by Wall St. Rank hold TTPH as of Q3 2019.

  • Jane Street reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
  • Jane Street sold 12,731 Tetraphase Pharmaceuticals, Inc. shares in Q3 2019, an estimated $122K.
  • Jane Street first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2015 and held it in 6 quarters.
  • Jane Street's Tetraphase Pharmaceuticals, Inc. position peaked at $264K in Q2 2015.
  • 26 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2019.

Based on Jane Street's 13F filing for Q3 2019, filed 14 Nov 2019.